WENDY HOLMES: Open Payments
NPI 1982827598 · MERIDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 25 payments from 16 companies in 2025. Trend: 2023 $541 · 2024 $496 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation | 1 | $125 |
| Astellas Pharma US Inc | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| PFIZER INC. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| SpringWorks Therapeutics, Inc. | 2 | $48 |
| JAZZ PHARMACEUTICALS INC. | 2 | $36 |
| Genmab U.S., Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $26 |
Products named: RYTELO, Vyloy, PADCEV, Nubeqa, OGSIVEO, ZEPZELCA, Tivdak, TAGRISSO.
Industry payments across CT — which companies pay providers there.
